U. Schenck

TL;DR: An overview of the fundamental points and principles that should support any quality-assured screening programme and key performance indicators are presented here in a summary document of the second guidelines edition in order to make these principles and standards known to a wider scientific community.

TL;DR: The following short annexe to Chapter 3 of the European Guidelines for Quality Assurance in Cervical Cancer Screening provides a framework that will allow different terminologies and languages to be translated into standard terminology based on the Bethesda system for cytology while retaining the cervical intraepithelial neoplasia (CIN) classification for histology.

TL;DR: Combined ERCP- and EUS-guided tissue acquisition seems to be the best approach to tissue diagnosis of indeterminate biliary strictures and pancreatic tumors.

TL;DR: The first part of Chapter 6 of the second edition of the European Guidelines for Quality Assurance in Cervical Cancer Screening as discussed by the authors provides guidance on how to manage women with abnormal cervical cytology.

TL;DR: The characteristics, indications and possible complications of excisional and ablative treatment methods, and some general advice on how to communicate screening, diagnosis and treatment results to the woman concerned are described.